Fortress Biotech
FBIO
$1.80
Share price
3.45%
Change (1 day)
136.84%
Change (1 year)
Categories
Earnings for Fortress Biotech (FBIO)
Earnings in 2023 (TTM): -$0.16 B
According to Fortress Biotech 's latest financial reports the company's current earnings (TTM) are -$0.16 B. In 2022 the company made an earning of -$0.22 B a decrease over its 2021 earnings that were of -$0.17 B.The earnings displayed on this page is the company's Pretax Income.
Earnings history for Fortress Biotech from 2011 to 2023
Annual earnings
| Year | Earnings | Change |
|---|---|---|
2023 (TTM)  | -$0.16 B | -28.03% |
| 2022 | -$0.22 B | 29.88% |
| 2021 | -$0.17 B | 59.8% |
| 2020 | -$0.11 B | 1.17% |
| 2019 | -$0.11 B | -19.84% |
| 2018 | -$0.13 B | 28.99% |
| 2017 | -$98.33 M | 37.92% |
| 2016 | -$71.29 M | 32.31% |
| 2015 | -$53.89 M | 164.31% |
| 2014 | -$20.39 M | -45.14% |
| 2013 | -$37.16 M | 37.55% |
| 2012 | -$27.02 M | -22.91% |
| 2011 | -$35.05 M |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 Veracyte VCYT | -$76.6 M | -50.14% | 🇺🇸 USA |
 Dicerna Pharmaceuticals DRNA | -$0.12 B | -23.42% | 🇺🇸 USA |
 Advaxis ADXS | -$34.03 M | -77.85% | 🇺🇸 USA |
 Dynavax Technologies
DVAX | $2.66 M | -101.74% | 🇺🇸 USA |